Related Experiment Video
Updated: Mar 1, 2026
Quantitative Multispectral Analysis Following Fluorescent Tissue Transplant for Visualization of Cell Origins, Types, and Interactions
Published on: September 22, 2013
Advanced imaging of transplant survival, fate, differentiation, and integration
Nadja Van Camp1, Elsa Diguet2, Philippe Hantraye1
1CEA, DSV, Molecular Imaging Research Center (MIRCen), Fontenay-aux-Roses, France; CNRS, CEA, Paris-Sud University, University of Paris-Saclay, Neurodegenerative Diseases Laboratory (UMR9199), Fontenay-aux-Roses, France.
Abstract:
Stem cell-based therapy trials for the treatment of neurodegenerative diseases such as Parkinson's and Huntington's disease are being actively prepared both at the preclinical and clinical level. Preclinical validation of these stem cell transplantations necessitates to implement a translational continuum to take one pluripotent stem cell through the point of "first-in-man" clinical trial. Main steps along this translational continuum include stem cell GMP production, in vitro optimization of differentiation protocols necessary to direct stem cells to the desired neuronal phenotype, and evaluation of functional efficacy in animal models including large animal models. Whereas the first two steps only require in vitro techniques and can be expedited smoothly, the last step is generally time consuming as functional assessment requires transplantation of the animal models with sufficient time for cells to develop, reconnect, and exert their therapeutic effect (around 40 weeks for human cells in the rodent brain). In such a context, brain imaging techniques that allow noninvasive longitudinal evaluation/characterization of the grafted cells in the living animals have the potential to speed-up the evaluation of candidate cell lines. This chapter describes an assemblage of imaging methods that over the years proved useful in preclinical and clinical applications for cell therapy, providing in a noninvasive way unique insights on graft cellular composition, phenotypic differentiation, as well as signs of hyperproliferation and/or immunological rejection and inflammation.
Insights
Brain imaging techniques accelerate stem cell therapy evaluation for neurodegenerative diseases by enabling noninvasive monitoring of transplanted cells in animal models, speeding up clinical translation.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Biomedical Imaging
Background:
- Stem cell-based therapies show promise for neurodegenerative diseases like Parkinson's and Huntington's.
- Translational research requires robust preclinical validation before human trials.
- Evaluating transplanted cell efficacy in animal models is a lengthy process.
Purpose of the Study:
- To highlight the importance of noninvasive brain imaging in accelerating stem cell therapy development.
- To review imaging methods for longitudinal assessment of cell grafts in preclinical models.
- To demonstrate how imaging aids in evaluating graft composition, differentiation, and safety.
Main Methods:
- Review of various brain imaging techniques applicable to cell therapy.
- Focus on noninvasive methods for longitudinal monitoring of transplanted cells.
- Application in preclinical studies for neurodegenerative disease models.
Main Results:
- Imaging techniques provide insights into graft cellularity, phenotype, and proliferation.
- Noninvasive monitoring can detect signs of immune rejection and inflammation.
- These methods significantly reduce the time needed for preclinical efficacy assessment.
Conclusions:
- Brain imaging is crucial for the translational continuum of stem cell therapies.
- Noninvasive imaging accelerates the evaluation of candidate cell lines for neurodegenerative diseases.
- This approach facilitates the progression of stem cell therapies towards clinical application.
